$57.5MSeries D, 5 June 2025
Series D equity (plus separate venture debt line) to advance ATX101.
- Amount
- $57.5M
- Stage
- Series D
- Announced
- 5 June 2025
- Lead
- Lightstone Ventures
- Other investors
- ClavystBio, NEA, Arboretum Ventures, Vertex Growth, Brandon Capital, EDBI, SGInnovate
- Use of funds
- Series D equity (plus separate venture debt line) to advance ATX101.
- Checked
- Announced by the company
- Sources
- Allay Therapeutics raises $57.5M Series D businesswire.com
Allay Therapeutics raises $57.5M Series D news.crunchbase.com